RT Journal Article
SR Electronic
T1 Preventing COVID-19 spread in closed facilities by regular testing of employees – an efficient intervention in long-term care facilities and prisons
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.12.20211573
DO 10.1101/2020.10.12.20211573
A1 H. Christian Tsoungui Obama, Jr.
A1 M. Y. Nessma Adil
A1 N. Looli Alawam
A1 Pierre M. Ngougoue N.
A1 Gideon A. Ngwa
A1 Miranda Teboh-Ewungkem
A1 Kristan A. Schneider
YR 2020
UL http://medrxiv.org/content/early/2020/10/14/2020.10.12.20211573.abstract
AB Background Draconic control measures were introduced to contain the global COVID-19 pandemic, many of which have been controversial, particularly the comprehensive use of diagnostic tests. Regular testing of high-risk individuals (pre-existing conditions, older than 60 years of age) has been suggested by public health authorities. The WHO suggested the use of routine screening of residents, employees, and visitors of long-term care facilities (LTCF) to protect the resident risk group. Similar suggestions have been made by the WHO for other closed facilities including incarceration facilities (e.g., prisons or jails), where in parts of the US, accelerated release of approved inmates is taken as a measure to mitigate COVID-19.Methods and findings Here, the simulation model underlying the pandemic preparedness tool CovidSim 1.1 (http://covidsim.eu/) is extended to investigate the effect of regularly testing of employees in order to protect immobile resident risk groups in closed facilities. The reduction in the number of infections and deaths within the risk group are investigated as well as the potential economic gain resulting from savings in COVID-19 related treatment costs in comparison to costs resulting from the testing interventions. Our simulations are adjusted to reflect the situation of LTCFs in the Federal Republic of Germany.The probability is nearly one that COVID-19 spreads into closed facilities due to contact with infected employees even under strict confinement of visitors in a pandemic scenario without targeted protective measures. Regular screening of all employees by PCR tests provides a significant reduction of COVID-19 cases and related deaths in LTCFs. While the frequency of testing (testing rate) and the quality of tests have noticeable effects, the waiting time for obtaining test results (ranging from 12 up to 96 hours) hardly impacts the outcome. The results suggest that testing every two weeks with low-quality tests and a processing time of up to 96 hours yields a strong reduction in the number of cases. Rough estimates suggest a significant economic gain.Conclusions The introduction of COVID-19 in closed facilities is unavoidable without thorough screening of persons that can introduce the disease into the facility. These measures provide an economically meaningful way to protect vulnerable risk groups characterized by an elevated risk of severe infections in closed facilities, in which contact-reducing measures are difficult to implement due to imminent unavoidable close human-to-human contacts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by grants of the German Academic Exchange (DAAD; https://www.daad.de/de/; Project-ID 57417782 and DAAD; Project-ID 57479556), the Saechsisches Staatsministerium für Wissenschaft, Kultur und Tourismus and Saechsische Aufbaubank - Foerderbank (SMWK-SAB; https://www.smwk.sachsen.de/; https://www.sab.sachsen.de/; project "Innovationsvorhaben zur Profilschaerfung an Hochschulen fuer angewandte Wissenschaften", Project-ID 100257255), the Federal Ministry of Education and Research (BMBF) and the DLR (Project-ID 01DQ20002; https://www.bmbf.de/; https://www.dlr.de/) to KAS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is based on simulations and can be reproduced.